Production of macrophage migration inhibitory factor by human and murine neuroblastoma

Tumor Biology

Volumn 23, Issue 3, 2002, Pages 123-129

  Bin, Qian ^a   Johnson, Bryon D ^a   Schauer, Dennis W ^a   Casper, James T ^a   Orentas, Rimas J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Macrophage migration inhibitory factor; MIF; Neuroblastoma; Tumor derived cytokines

Indexed keywords

CYTOKINE; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; RIBONUCLEASE; RNA; TUMOR DERIVED CYTOKINE; MESSENGER RNA;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; ASSAY; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; MACROPHAGE MIGRATION ASSAY; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR CELL CULTURE; TUMOR CELL LINE; TUMOR GROWTH; ANIMAL; BIOSYNTHESIS; CELL CULTURE; LEUKOCYTE MIGRATION INHIBITION TEST; METABOLISM; MOUSE;

ANIMALS; CELL MIGRATION INHIBITION; HUMANS; INTERLEUKIN-6; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; NEUROBLASTOMA; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0036559387     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064028     Document Type: Article

References (41)

1. Isaacs H Jr: Neuroblastoma. Tumors of the Fetus and Newborn. Philadelphia, Saunders, 1997.
2. Brodeur GM, Castleberry RP: Neuroblastoma; in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology. Philadelphia, Lippincott-Raven, 1997.
3. Katoka Y, Matsumura T, Yamamoto S, Sugimoto S, Sawada T: Distinct cytotoxicity against neuroblastoma cells of peripheral blood and tumor-infiltrating lymphocytes from patients with neuroblastoma. Cancer Lett 1993;73:11-21.
4. Fowler CL, Brooks SP, Rossman JE, Cooney DR: Combined preoperative and postoperative immunotherapy for C1300 neuroblastoma. J Pediatr Surg 1993;28:420-427.
5. Kuge S, Watanabe K, Makino K, Tokuda Y, Mitomi T, Kawamura N, Habu S, Nishimura T: Interleukin-12 augments the generation of autologous tumor-reactive CD8+ cytotoxic T lymphocytes from tumor-infiltrating lymphocytes: Jpn J Cancer Res 1995;86:135-139.
6. Foreman NK, Rill DR, Coustan-Smith E, Douglass EC, Brenner MK: Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication. Br J Cancer 1993;67:933-938.
7. Katsanis E, Orchard PJ, Bausero MA, Gorden KB, McIvor RS, Blazar BR: Interleukin-2 gene transfer into murine neuroblastoma decreases tumorigenicity and enhances systemic immunity causing regression of preestablished retroperitoneal tumors. J Immunother 1997;15:81-90.
8. Truitt RL, Piaskowski V, Kirchner P, McOlash L, Camitta BM, Casper JT: Immunologic evaluation of pediatric cancer patients receiving recombinant interleukin-2 in a phase I trial. J Immunother 1992;11:274-285.
9. Ziegler MM, Ishizu H, Nagabuchi E, Takada N, Arya G: A comparative review of the immunobiology of murine neuroblastoma and human neuroblastoma. Cancer 1997;79:1757-1766.
10. Knezevic-Cuca J, Stansberry KB, Johnston G, Zhang J, Keller ET, Vinik AI, Pittenger GL: Neurotrophic role of interleukin-6 and soluble interleukin-6 receptors in N1E-115 neuroblastoma cells. J Neuroimmunol 2000;102:8-16.
11. Goswami S, Gupta A, Sharma SK: Interleukin-6-mediated autocrine growth promotion in human glioblastoma multiforme cell line U87MG. J Neurochem 1998;71:1837-1845.
12. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R: MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993;365:756-759.
13. Nishino T, Bernhagen J, Shiiki H, Calandra T, Dohi K, Bucala R: Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol Med 1995;7:781-788.
14. Kleeman R, Rorsman H, Rosengren E, Mischke R, Mai NT, Bernhagen J: Dissection of the enzymatic and immunologic functions of macrophage migration inhibitory factor. Eur J Biochem 2000;267:7183-7192.
15. Calandra T, Bernhagen J, Mitchell RA, Bucala R: The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994;179:1895-1902.
16. Jüttner S, Bernhagen J, Metz CN, Röllinghoff M, Bucala R, Gessnser A: Migration inhibitory factor induces killing of Leishmania major by macrophages: Dependence on reactive nitrogen intermediates and endogenous TNF-α. J Immunol 1998;161:2383-2390.
17. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R: An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 1999;5:181-191.
18. Ogawa H, Nishihara J, Sato Y, Kondo M, Takahashi N, Oshima T, Todo S: An antibody for macrophage migration inhibitory factor suppresses tumor growth and inhibits tumor-associated angiogenesis. Cytokine 2000;12:309-314.
19. Abe R, Peng T, Sailors J, Bucala R, Metz CN: Regulation of the CTL response by macrophage migration inhibitory factor. J Immunol 2001;166:747-753.
20. Barker E, Mueller BM, Handgretinger R, Herter M, Yu AL, Reisfeld R: Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells. Cancer Res 1991;51:144-149.
21. Gordon MR, Chida K, Takata I, Myrvik QN: Macrophage migration inhibition induced by MDP, LPS, PMA, and MIF/MAF: Reversal by macrophage migration enhancement factor (MEF), L-fucose, L-fucosyl BSA, D-mannose, and D-mannosyl BSA. J Leukoc Biol 1987;42:197-203.
22. Bernhagen J, Bacher M, Calandra T, Metz CN, Doty SB, Donnelly T, Bucala R: An essential role for macrophage migration inhibitory factor in tuberculin delayed-type hypersensitivity reaction. J Exp Med 1996;183:277-282.
23. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donelly T, Cerami A, Bucala R: MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377:68-71.
24. Calandra T, Spiegel LA, Metz CN, Bucala R: Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Natl Acad Sci USA 1998;95:11383-11388.
25. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihara J: Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arlhritis. J Biol Chem 2000;275:444-450.
26. Shimizu T, Abe R, Nakamura H, Ohkawara A, Suzuki M, Nishihira J: High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem Biophys Res Commun 1999;264:751-758.
27. Kleeman R, Hausser A, Geiger G, Mischke, R, Burger-Kentischer A, Flieger O, Johannes F-J. Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J: Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jabl. Nature 2000;408:211-216.
28. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH: A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 1999;190:1375-1382.
29. Apte RS, Sinha D, Mayhew E, Wistow GJ, Niederkorn JY: Role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol 1998;160:5693-5696.
30. Kitaichi N, Ogasawara K, Iwabuchi K, Nishihira J, Namba K, Onoe K, Konishi J, Kotake J, Matsuda H, Onoe K: Different influence of macrophage migration inhibitory factor (MIF) in signal transaction pathway of various T cell subsets. Immunobiology 2000;201:356-367.
31. Ferrer FA, Pantschenko AG, Miller LJ, Anderson K, Grunnet M, McKenna PH, Kreutzer D: Angiogenesis and neuroblastomas: Interleukin-8 and interleukin-8 receptor expression in human neuroblastoma. J Urol 2000;164:1016-1020.
32. Satoh J, Kurohara K, Yukitake M, Kuroda Y: Interleukin-15, a T-cell growth factor, is expressed in human neural cell lines and tissues. J Neurol Sci 1998;155:170-177.
33. Condorelli F, Sortino MA, Stella AM, Canonico PL: Relative contribution of different receptor subtypes in the response of neuroblastoma cells to tumor necrosis factor-alpha. J Neurochem 2000;75:1172-1179.
34. Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R: Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 1994;33:14144-14155.
35. Pastrana DV, Raghavan N, Fitzgerald P, Eisinger SW, Metz C, Bucala R, Schleimer RP, Bickcl C, Scott AL: Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor. Infect Immun 1998;66:5955-5963.
36. Kovalchuk LV, Khoroshilova-Maslova IP, Gankovskaya LV, Krainova TA, Gimorova RA, Ilatovskaya LV, Marteushev AV, Tumanov AV: Natural complex of cytokines is a potent stimulant to posttraumatic regeneration in rabbit cornea. J Ocul Pharmacol Ther 1996;12:271-279.
37. Abe R, Shimizu AR, Ohkawara A, Nishihira J: Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts. Biochim Biophys Acta 2000;1500:1-9.
38. Hermanowski-Vosatka A, Mundt SS, Ayala JM, Goyal S, Hanlon WA, Czerwinski RM, Wright SD, Whitman CP: Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration. Biochemistry 1999;38:12841-12849.
39. Kamimura A, Kamachi M, Nishihira J, Ogura S, Isobe H, Dosaka-Okuta H, Ogata A, Shindoh M, Ohbuchi T, Kawakami Y: Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung. Cancer 2000;89:334-341.
40. Bernhagen J, Calandra T, Bucala R: Regulation of the immune response by macrophage migration inhibitory factor: Biological and structural features. J Mol Med 1998;76:151-161.
41. Mitchell RA, Bucala R: Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). Semin Cancer Biol 2000;10:359-366.